MedPath

PharmaDax Inc.

PharmaDax Inc. logo
🇨🇳China
Ownership
Private
Established
2008-01-01
Employees
251
Market Cap
-
Website
http://www.pharmadax.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

Phase 2
Conditions
Keratoconjunctivitis Sicca
Dry Eye Syndrome
Interventions
Drug: Pro-ocular™ Topical Gel
Drug: Placebo Topical Gel
First Posted Date
2021-05-12
Last Posted Date
2021-05-14
Lead Sponsor
PharmaDax Inc.
Target Recruit Count
80
Registration Number
NCT04884217
Locations
🇨🇳

Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.